CLINICAL_TRIALS
trial_result
· 2018-01-29
Clinical Trial Update: PROvenge Treatment and Early Cancer Treatment [Phase 3]
Summary
Phase 3 trial update for PROvenge (sipuleucel-T) in prostate cancer with completed results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Dendreon | Conditions: Prostate Cancer | Phase 3 | Status: COMPLETED | Results posted: 2018-01-29